Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/2/26 16:05 | 6/1/26 | GLUE | Health | BioPrd | Biological Products, (No Diag | Warmuth Markus | MA | DO | P,CEO | 6 | S.d | -731 | 18.27 | 0 | -40 | 624 | D | |||||||||||||||
6/1/26 16:05 | 5/29/26 | GLUE | Health | BioPrd | Biological Products, (No Diag | Townson Sharon | MA | O | Chief Sc | 2 | S.d | -167 | 18.25 | 0 | -9 | 68 | D | |||||||||||||||
5/28/26 19:10 | 5/27/26 | GLUE | Health | BioPrd | Biological Products, (No Diag | Champoux Jennifer | MA | O | COO | 3 | S.d | -125 | 17.87 | 0 | -7 | 62 | D | |||||||||||||||
5/22/26 16:05 | 5/21/26 | GLUE | Health | BioPrd | Biological Products, (No Diag | Manning Anthony M. | MA | D | 1 | S.d | -180 | 18.01 | 0 | -10 | -100 | 0 | D | |||||||||||||||
4/10/26 16:07 | 4/9/26 | GLUE | Health | BioPrd | Biological Products, (No Diag | Nickson Philip | MA | O | Chief Bu | 2 | S.d | -151 | 16.81 | 0 | -9 | 61 | D | |||||||||||||||
3/5/26 17:24 | 3/4/26 | GLUE | Health | BioPrd | Biological Products, (No Diag | Dunn Edmund | MA | O | Principa | 4 | S.dm | -492 | 17.01 | 0 | -29 | 24 | D | |||||||||||||||
2/24/26 16:05 | 2/23/26 | GLUE | Health | BioPrd | Biological Products, (No Diag | Janku Filip | MA | O | Chief Me | 2 | S.d | -227 | 18.39 | 0 | -12 | 75 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |